Copyright © 2019. Inderes Oy. All rights reserved.
Search
User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
Nexstim
2297 investors follow this company
The company is not covered. See all listed companies from here.
BUY 0.08 LOWEST 0.08 VOLUME 1 118 205
SELL 0.08 HIGHEST 0.09 VALUE 0,093 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Upcoming events

28
Feb
Tilinpäätöstiedotteet

Latest insider trading

Type: stock_exchange_release
16.1.
2020

Company announcement, Helsinki, 16 January 2020 at 1.30 PM (EET)

Nexstim Plc‘s Technology Licencing Discussions Ended with a Leading California Based Academic Institution

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announced on October 2, 2019 that it had entered in licensing negotiations with a leading California based academic institution.

Type: stock_exchange_release
23.12.
2019

Company announcement, Helsinki, 23 December 2019 3.00 pm (EET)

Nexstim Plc’s Financial Information in 2020

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will publish the following financial information in 2020:

The 2019 Financial Statements Release and Half-Yearly Report July−December 2019 (H2) on Friday, February 28, 2020. Half-Yearly Report January-June 2020 (H1) on Friday, August 14, 2020.

Type: stock_exchange_release
18.12.
2019

Company announcement, insider information, Helsinki, 18 December 2019 at 9.00 am (EET)

Nexstim Plc’s Board of Directors resolved on a directed share issue of approximately 141 thousand euro to Kreos Capital V (UK) Limited

Type: stock_exchange_release
5.12.
2019

 Company announcement, Helsinki, 5 December 2019 at 11.10 am (EET)

Nexstim Plc: Health Canada Grants Nexstim NBT® Medical Device License for Canada

Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada.

The medical device license allows Nexstim to start marketing and commercial distribution of the NBT® system for the treatment of Major Depressive Disorder (MDD) in Canada.

Type: stock_exchange_release
2.12.
2019

Press Release, Helsinki, 2 December 2019 at 10 am (EET)

Nexstim NBT® System with SmartFocus® TMS installed at Rockford Psychiatric Medical Services, US

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Rockford Psychiatric Medical Services has started using Nexstim NBT® System with SmartFocus® TMS technology.

Type: stock_exchange_release
26.11.
2019

Press Release, Helsinki, 26 November 2019 at 12.30 pm (EET)

Nexstim has received four new NBS System orders in October-November

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received four new NBS System orders in October and November 2019.

The orders have come from four different clinics located in the United States, Russia, Finland and Germany.

Type: stock_exchange_release
18.11.
2019

Company announcement, Helsinki, 18 November at 9 am (EET)

Nexstim Plc: Shares subscribed for in the directed share issue have been registered

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announced on 15 November 2019 that an aggregate of 15,687,350 new shares of Nexstim were subscribed for in the directed share issue. Such new shares have today been registered with the Trade Register.

Type: stock_exchange_release
15.11.
2019

Company announcement, Inside information, Helsinki, 15 November at 6.30 pm (EET)

Nexstim Plc: In total 15,687,350 shares subscribed in the directed share issue

Type: stock_exchange_release
11.11.
2019

Company announcement, insider information, Helsinki, 11 November 2019 at 2 PM (EET)

Nexstim Plc has decided on a directed share issue of approximately EUR 1.8 million based on authorization of the Extraordinary General Meeting of Shareholders

Type: stock_exchange_release
11.11.
2019

Press Release, Helsinki, 11 November 2019 at 12.20 pm (EET)

Dr. Leena Niemistö starts as new Chair of the Board of Nexstim Plc

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that the Extraordinary General Meeting of Shareholders has elected Leena Niemistö as the new Chair of the Board of Directors.

Nexstim

English translation unavailable for Nexstim.
Nexstim lyhyesti